Although we did not find a statistically significant association between tumor size and IQGAP2 expression in patients, our in vitro and in vivo (xenograft model) results clearly showed the anti-proliferative role of IQGAP2 in breast cancer, which is consistent with the prior findings of IQGAP2 in other cancer types9–12. Here, IQGAP2 is linked to cancer.